Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 127
Filtrar
1.
Tissue Antigens ; 81(3): 141-9, 2013 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-23398507

RESUMO

The human leukocyte antigen (HLA) class I and class II loci are the most polymorphic genes in the human genome; distinguishing the thousands of HLA alleles is challenging. Next generation sequencing of exonic amplicons with the 454 genome sequence (GS) FLX System and Conexio Assign ATF 454 software provides high resolution, high throughput HLA genotyping for eight class I and class II loci. HLA typing of potential donors for unrelated bone marrow donor registries typically uses a subset of these loci at high sample throughput and low cost per sample. The Fluidigm Access Array System enables the incorporation of 48 different multiplex identifiers (MIDs) corresponding to 48 genomic DNA samples with up to 48 different primer pairs in a microfluidic device generating 2304 parallel polymerase chain reactions (PCRs). Minimal volumes of reagents are used. During genomic PCR, in this 4-primer system, the outer set of primers containing the MID and the 454 adaptor sequences are incorporated into an amplicon generated by the inner HLA target-specific primers each containing a common sequence tag at the 5' end of the forward and reverse primers. Pools of the resulting amplicons are used for emulsion PCR and clonal sequencing on the 454 Life Sciences GS FLX System, followed by genotyping with Conexio software. We have genotyped 192 samples with 100% concordance to known genotypes using 8 primer pairs (covering exons 2 and 3 of HLA-A, B and C, and exon 2 of DRB1, 3/4/5 and DQB1) and 96 MIDs in a single GS FLX run. An average of 166 reads per amplicon was obtained. We have also genotyped 96 samples at high resolution (14 primer pairs covering exons 2, 3, and 4 of the class I loci and exons 2 of DRB1, 3/4/5, DQA1, DQB1, DPB1, and exon 3 of DQB1), recovering an average of 173 sequence reads per amplicon.


Assuntos
Biblioteca Gênica , Técnicas de Genotipagem/métodos , Sequenciamento de Nucleotídeos em Larga Escala/métodos , Teste de Histocompatibilidade/métodos , Microfluídica/métodos , Análise de Sequência de DNA/métodos , Linhagem Celular , Primers do DNA/metabolismo , Humanos , Reação em Cadeia da Polimerase , Software
2.
Clin Pharmacol Ther ; 89(5): 718-25, 2011 May.
Artigo em Inglês | MEDLINE | ID: mdl-21430657

RESUMO

We explored whether breast cancer outcomes are associated with endoxifen and other metabolites of tamoxifen and examined potential correlates of endoxifen concentration levels in serum including cytochrome P450 2D6 (CYP2D6) metabolizer phenotype and body mass index (BMI). Concentration levels of tamoxifen, endoxifen, 4-hydroxytamoxifen (4OH-tamoxifen), and N-desmethyltamoxifen (ND-tamoxifen) were measured from samples taken from 1,370 patients with estrogen receptor (ER)-positive breast cancer who were participating in the Women's Healthy Eating and Living (WHEL) Study. We tested these concentration levels for possible associations with breast cancer outcomes and found that breast cancer outcomes were not associated with the concentration levels of tamoxifen, 4-hydroxytamoxifen, and ND-tamoxifen. For endoxifen, a threshold was identified, with women in the upper four quintiles of endoxifen concentration appearing to have a 26% lower recurrence rate than women in the bottom quintile (hazard ratio (HR) = 0.74; 95% confidence interval (CI), (0.55-1.00)). The predictors of this higher-risk bottom quintile were poor/intermediate metabolizer genotype, higher BMI, and lower tamoxifen concentrations as compared with the mean for the cohort as a whole. This study suggests that there is a minimal concentration threshold above which endoxifen is effective against the recurrence of breast cancer and that ~80% of tamoxifen takers attain this threshold.


Assuntos
Neoplasias da Mama/enzimologia , Neoplasias da Mama/genética , Citocromo P-450 CYP2D6/genética , Tamoxifeno/análogos & derivados , Tamoxifeno/metabolismo , Neoplasias da Mama/tratamento farmacológico , Estudos de Coortes , Feminino , Genótipo , Humanos , Pessoa de Meia-Idade , Fenótipo , Tamoxifeno/sangue , Tamoxifeno/uso terapêutico , Resultado do Tratamento
3.
Neuroscience ; 146(4): 1677-88, 2007 Jun 08.
Artigo em Inglês | MEDLINE | ID: mdl-17467185

RESUMO

Serotonin (5-HT) action via the 5-HT(2C) receptor (5-HT(2C)R) provides an important modulatory influence over neurons of the prefrontal cortex (PFC), which is critically involved in disorders of executive function including substance use disorders. In the present study, we investigated the distribution of the 5-HT(2C)R in the rat prelimbic prefrontal cortex (PrL), a subregion of the medial prefrontal cortex (mPFC), using a polyclonal antibody raised against the 5-HT(2C)R. The expression of 5-HT(2C)R immunoreactivity (IR) was highest in the deep layers (layers V/VI) of the mPFC. The 5-HT(2C)R-IR was typically most intense at the periphery of cell bodies and the initial segment of cell processes. Approximately 50% of the 5-HT(2C)R-IR detected was found in glutamate decarboxylase, isoform 67 (GAD 67)-positive neurons. Of the subtypes of GABA interneurons identified by expression of several calcium-binding proteins, a significantly higher percentage of neurons expressing IR for parvalbumin also expressed 5-HT(2C)R-IR than did the percentage of neurons expressing calbindin-IR or calretinin-IR that also expressed 5-HT(2C)R-IR. Since parvalbumin is located in basket and chandelier GABA interneurons which project to cell body and initial axon segments of pyramidal cells, respectively, these results raise the possibility that the 5-HT(2C)R in the mPFC acts via the parvalbumin-positive GABAergic interneurons to regulate the output of pyramidal cells in the rat mPFC.


Assuntos
Neurônios/metabolismo , Córtex Pré-Frontal/citologia , Receptor 5-HT2C de Serotonina/metabolismo , Ácido gama-Aminobutírico/metabolismo , Animais , Proteínas de Ligação ao Cálcio/metabolismo , Contagem de Células/métodos , Glutamato Descarboxilase/metabolismo , Masculino , Proteínas do Tecido Nervoso/metabolismo , Ratos , Ratos Sprague-Dawley
4.
Gene Ther ; 13(3): 206-15, 2006 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-16307003

RESUMO

Although a significant negative prognostic factor, tumor hypoxia can be exploited for gene therapy. To maximize targeting within the tumor mass, we have developed synthetic gene promoters containing hypoxia-responsive elements (HREs) from the erythropoietin (Epo) gene as well as radiation-responsive CArG elements from the early growth response (Egr) 1 gene. Furthermore, to achieve high and sustained expression of the suicide gene herpes simplex virus thymidine kinase (HSVtk), our gene therapy vectors contain an expression amplification system, or 'molecular switch', based on Cre/loxP recombination. In human glioma and breast adenocarcinoma cells exposed to hypoxia and/or radiation, the HRE/CArG promoter rapidly activated Cre recombinase expression leading to selective and sustained HSVtk synthesis. Killing of transfected tumor cells was measured after incubation with the prodrug ganciclovir (GCV; converted by HSVtk into a cytotoxin). In vitro, higher and more selective GCV-mediated toxicity was achieved with the switch vectors, when compared with the same inducible promoters driving HSVtk expression directly. In tumor xenografts implanted in nude mice, the HRE/CArG-switch induced significant growth delay and tumor eradication. In conclusion, hypoxia- and radiation-activated 'molecular switch' vectors represent a promising strategy for both targeted and effective gene therapy of solid tumors.


Assuntos
Adenoviridae/genética , Terapia Genética/métodos , Vetores Genéticos/genética , Neoplasias/terapia , Terapia Viral Oncolítica/métodos , Adenocarcinoma/patologia , Adenocarcinoma/terapia , Animais , Antivirais/uso terapêutico , Neoplasias Encefálicas/patologia , Neoplasias Encefálicas/terapia , Neoplasias da Mama/patologia , Neoplasias da Mama/terapia , Morte Celular , Hipóxia Celular , Terapia Combinada , Proteína 1 de Resposta de Crescimento Precoce/genética , Eritropoetina/genética , Ganciclovir/uso terapêutico , Regulação Neoplásica da Expressão Gênica , Genes de Troca , Genes Transgênicos Suicidas , Engenharia Genética/métodos , Vetores Genéticos/administração & dosagem , Vetores Genéticos/efeitos da radiação , Glioma/patologia , Glioma/terapia , Humanos , Camundongos , Camundongos Nus , Neoplasias/patologia , Regiões Promotoras Genéticas , Simplexvirus/enzimologia , Timidina Quinase/biossíntese , Timidina Quinase/metabolismo , Células Tumorais Cultivadas
5.
Conf Proc IEEE Eng Med Biol Soc ; 2004: 1455-8, 2004.
Artigo em Inglês | MEDLINE | ID: mdl-17271969

RESUMO

This paper presents a photo-identification algorithm using Zernike moment invariants embedded in a subspace optimal for pattern identification. Fisher discriminants are used and the invariants are projected onto the subspace spanned by the Fisher basis vectors. The technique has been applied to photo-identification of gray whales (Eschrichtius robustus) using their field images. White patches (blotches) appearing on a gray whale's left and right flukes constitute unique identifying features and have been used here for individual identification. The fluke area is extracted from a fluke image via the live-wire edge detection algorithm, followed by optimal thresholding of the fluke area to obtain the blotches. Zernike moment invariants are then calculated for the blotches and projected onto the subspace spanned by Fisher basis vectors. These invariants are used as the feature vector representing a database image. During matching, the database images are ranked depending on the degree of similarity between a query and database feature vectors. The results show that the use of this algorithm leads to a significant reduction in the amount of manual search that is normally done by marine biologists.

6.
Gene Ther ; 10(17): 1512-8, 2003 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-12900767

RESUMO

Tumor cells engineered by gene transduction to be MHC Class II+/Ii- are novel APCs capable of presenting endogenous tumor antigen epitopes to activate T helper cells. The MHC Class II+/Ii- tumor cell phenotype is created by transfecting genes for either CIITA or IFN-gamma, and inhibiting induced Ii mRNA by an Ii reverse gene construct (Ii-RGC). Adenoviral vectors are preferred for the delivery of such genes because of high infection efficiency and ubiquity of the adenoviral receptor on many cell types and tumors. Here we show that at 5 MOI (multiplicity of infection), recombinant adenoviruses with CIITA or IFN-gamma genes converted virtually all MC-38 colon adenocarcinoma cells and Renca renal carcinoma cells in culture to MHC Class II+/Ii+ cells. A single recombinant adenovirus with both genes for IFN-gamma and Ii-RGC (rAV/IFN-gamma/Ii-RGC) efficiently induced the MHC Class II+/Ii- phenotype. Injection of tumor nodules with rAV/Ii-RGC and rAV/CIITA/IFN-gamma combined with a suboptimal dose of rAV/IL-2 induced a potent antitumor immune response. The methods are adaptable for producing enhanced genetic vaccines, attenuated virus vaccines (eg, vaccinia), and ex vivo cell-based vaccines (dendritic and tumor cells).


Assuntos
Genes MHC da Classe II , Terapia Genética/métodos , Imunoterapia Adotiva/métodos , Neoplasias/terapia , RNA Antissenso/administração & dosagem , Adenoviridae/genética , Animais , Antígenos de Diferenciação de Linfócitos B/genética , Antígenos de Neoplasias/genética , Eletroporação , Engenharia Genética , Vetores Genéticos/administração & dosagem , Antígenos de Histocompatibilidade Classe II/genética , Injeções Subcutâneas , Interferon gama/genética , Camundongos , Fenótipo , Transdução Genética/métodos , Células Tumorais Cultivadas
7.
Clin Cancer Res ; 7(2): 382-90, 2001 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-11234894

RESUMO

We have shown previously that genistein, the major isoflavone in soybean, inhibited the growth of human prostate cancer cells in vitro by affecting the cell cycle and inducing apoptosis. To augment the effect of radiation for prostate carcinoma, we have now tested the combination of genistein with photon and neutron radiation on prostate carcinoma cells in vitro. The effects of photon or neutron radiation alone or genistein alone or both combined were evaluated on DNA synthesis, cell growth, and cell ability to form colonies. We found that neutrons were more effective than photons for the killing of prostate carcinoma cells in vitro, resulting in a relative biological effectiveness of 2.6 when compared with photons. Genistein at 15 microM caused a significant inhibition in DNA synthesis, cell growth, and colony formation in the range of 40-60% and potentiated the effect of low doses of 200-300 cGy photon or 100-150 cGy neutron radiation. The effect of the combined treatment was more pronounced than with genistein or radiation alone. Our data indicate that genistein combined with radiation inhibits DNA synthesis, resulting in inhibition of cell division and growth. Genistein can augment the effect of neutrons at doses approximately 2-fold lower than photon doses required to observe the same efficacy. These studies suggest a potential of combining genistein with radiation for the treatment of localized prostate carcinoma.


Assuntos
Antineoplásicos/farmacologia , Sobrevivência Celular/efeitos dos fármacos , Sobrevivência Celular/efeitos da radiação , DNA de Neoplasias/efeitos da radiação , Genisteína/farmacologia , Neoplasias da Próstata/radioterapia , Radiossensibilizantes/farmacologia , Células Tumorais Cultivadas/efeitos dos fármacos , Células Tumorais Cultivadas/efeitos da radiação , Apoptose/efeitos dos fármacos , Apoptose/efeitos da radiação , Divisão Celular/efeitos dos fármacos , Divisão Celular/efeitos da radiação , DNA/biossíntese , Raios gama , Humanos , Masculino , Neoplasias da Próstata/tratamento farmacológico , Timidina/química , Fatores de Tempo , Ensaio Tumoral de Célula-Tronco
8.
Clin Cancer Res ; 7(1): 136-44, 2001 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-11205901

RESUMO

We have shown that implantation of human prostate carcinoma PC-3 cells in the prostates of nude mice led to the formation of prostate tumors with metastases to para-aortic lymph nodes. We found that day 6 prostate tumors were responsive to systemic injections of interleukin 2 (IL-2) therapy. We have now investigated the combination of primary tumor irradiation and IL-2 for metastatic prostate cancer in this preclinical tumor model. The effect of neutron radiation was compared with that of photon radiation. Advanced prostate tumors (approximately 0.4 cm) were irradiated, and a day later, mice were treated with systemic IL-2 for three weekly cycles. In separate experiments, mice were either sacrificed on day 30 to assess prostate tumor size and tumor histology or followed for survival. A dose-dependent inhibition of prostate tumor growth was caused either by photons or neutrons, but neutrons were more effective than photons with a relative biological effectiveness of 2. The tumor inhibition obtained with 250 cGy neutrons and 500 cGy photons was significant (>75%) and was further increased (> or = 90%) by addition of IL-2 therapy. In survival studies, the combination of radiation and IL-2 showed a significant survival advantage compared with untreated mice (P < or = 0.005) or radiation alone (P < or = 0.003) and an increase in median survival compared with IL-2 alone. Histologically, the combined regimen resulted in a greater degree of tumor destruction, inflammatory response, and vascular damage than that observed with each modality alone. After this combined treatment, no tumor was histologically detected in the para-aortic lymph nodes of these mice, and the lymph nodes were significantly smaller. These findings showed that primary tumor irradiation, either with neutrons or photons, enhanced IL-2 therapeutic effect for the treatment of advanced prostate cancer. This combined modality induced an antitumor response that controlled the growth of prostate tumors and their metastases.


Assuntos
Adenocarcinoma/tratamento farmacológico , Adenocarcinoma/radioterapia , Interleucina-2/uso terapêutico , Neoplasias da Próstata/tratamento farmacológico , Neoplasias da Próstata/radioterapia , Radioterapia Conformacional/métodos , Adenocarcinoma/mortalidade , Animais , Relação Dose-Resposta à Radiação , Humanos , Injeções Intravenosas , Masculino , Camundongos , Recidiva Local de Neoplasia , Nêutrons , Fótons , Neoplasias da Próstata/mortalidade , Tolerância a Radiação , Fatores de Tempo , Resultado do Tratamento , Células Tumorais Cultivadas/efeitos da radiação
9.
Ostomy Wound Manage ; 47(5): 28-33, 2001 May.
Artigo em Inglês | MEDLINE | ID: mdl-11889720

RESUMO

This paper outlines the history and development of herbalism. The fall of medicinal herbs from favor and how recently they have returned to prominence are discussed, as well as the role of phytotherapy in successfully resolving chronic disease processes and managing wounds. The role of the herbalist is explained and includes a detailed description of the techniques employed by practitioners. Seven basic herbs are profiled regarding benefits, therapeutic potential, interactions, and effects. A hydrotherapy procedure for wound management is included.


Assuntos
Fitoterapia/métodos , Preparações de Plantas/uso terapêutico , Ferimentos e Lesões/tratamento farmacológico , Doença Crônica , Humanos , Hidroterapia/métodos
10.
Ann Biomed Eng ; 28(10): 1269-79, 2000.
Artigo em Inglês | MEDLINE | ID: mdl-11144987

RESUMO

This paper presents a syntactic/semantic string representation scheme as well as a string matching method as part of a computer-assisted system to identify dolphins from photographs of their dorsal fins. A low-level string representation is constructed from the curvature function of a dolphin's fin trailing edge, consisting of positive and negative curvature primitives. A high-level string representation is then built over the low-level string via merging appropriate groupings of primitives in order to have a less sensitive representation to curvature fluctuations or noise. A family of syntactic/semantic distance measures between two strings is introduced. A composite distance measure is then defined and used as a dissimilarity measure for database search, highlighting both the syntax (structure or sequence) and semantic (attribute or feature) differences. The syntax consists of an ordered sequence of significant protrusions and intrusions on the edge, while the semantics consist of seven attributes extracted from the edge and its curvature function. The matching results are reported for a database of 624 images corresponding to 164 individual dolphins. The identification results indicate that the developed string matching method performs better than the previous matching methods including dorsal ratio, curvature, and curve matching. The developed computer-assisted system can help marine mammalogists in their identification of dolphins, since it allows them to examine only a handful of candidate images instead of the currently used manual searching of the entire database.


Assuntos
Sistemas de Identificação Animal/métodos , Computadores , Golfinhos/anatomia & histologia , Sistemas de Identificação Animal/estatística & dados numéricos , Animais , Engenharia Biomédica , Bases de Dados Factuais , Biologia Marinha/métodos , Fotografação
11.
Comput Biomed Res ; 32(6): 503-16, 1999 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-10587468

RESUMO

We report a novel computer method for automatic labeling of structures in 3D MRI data sets using expert anatomical knowledge that is coded in fuzzy sets and fuzzy rules. The method first identifies major structures and then uses spatial relationships to these landmarks to recognize other structures. This labeling process simulates the iterative process that we ourselves use to locate structures in images. We demonstrate its application in three data sets, labeling brain MRI by locating the longitudinal and lateral fissures and the central sulci and then determining boundaries for the frontal lobes. Our method is adaptable to the identification of other anatomical structures.


Assuntos
Encéfalo/anatomia & histologia , Lógica Fuzzy , Imageamento por Ressonância Magnética/estatística & dados numéricos , Simulação por Computador , Interpretação Estatística de Dados , Sistemas Inteligentes , Humanos , Modelos Anatômicos , Modelos Neurológicos
12.
Cancer Detect Prev ; 23(5): 408-16, 1999.
Artigo em Inglês | MEDLINE | ID: mdl-10468893

RESUMO

We have tested an immunotherapy approach for the treatment of metastatic prostate carcinoma using a bone tumor model. Human PC-3 prostate carcinoma tumor cells were heterotransplanted into the femur cavity of athymic Balb/c nude mice. Tumor cells replaced marrow cells in the bone cavity, invaded adjacent bone and muscle tissues, and formed a palpable tumor at the hip joint. PC-3/IF cell lines, generated from bone tumors by serial in vivo passages, grew with faster kinetics in the femur and metastasized to inguinal lymph nodes. Established tumors were treated with systemic interleukin-2 (IL-2) injections. IL-2 significantly inhibited the formation of palpable tumors and prolonged mouse survival at nontoxic low doses. Histologically IL-2 caused vascular damage and infiltration of polymorphonuclear cells and lymphocytes in the tumor as well as necrotic areas with apoptotic cells. These findings suggest destruction of tumor cells by systemic IL-2 therapy and IL-2 responsiveness of prostate carcinoma bone tumors.


Assuntos
Neoplasias Ósseas/tratamento farmacológico , Neoplasias Ósseas/secundário , Interleucina-2/uso terapêutico , Neoplasias da Próstata/tratamento farmacológico , Animais , Neoplasias Ósseas/patologia , Humanos , Masculino , Camundongos , Camundongos Endogâmicos BALB C , Transplante de Neoplasias , Neoplasias da Próstata/complicações , Fatores de Tempo , Transplante Heterólogo , Células Tumorais Cultivadas
13.
Cancer Detect Prev ; 23(4): 333-42, 1999.
Artigo em Inglês | MEDLINE | ID: mdl-10403905

RESUMO

The treatment of prostate carcinoma is dependent on the stage of the disease. Patients who present with clinically localized cancer or locally advanced tumors can be potentially cured by radical prostatectomy, radiation, and hormonal therapy. However, disease progression can occur in 30-50% of patients diagnosed with clinically localized cancer. The bone is the predominant site of metastases. Metastatic prostate cancer is first treated by androgen blockade but within a few months becomes hormone refractory. Hormone refractory metastatic prostate cancer is not responsive to conventional treatments, and patients have an expected survival of less than a year. It is essential to develop new approaches for the treatment of hormone refractory metastatic disease. Immunotherapy, based on enhancement of the host immune response against the tumor, has been used as an alternative therapy for the treatment of metastatic cancers refractory to conventional therapy in particular for melanoma and renal cell carcinoma. In this review, we will summarize various immunotherapeutic approaches developed over the last 18 years, and we will address the potential of immunotherapy for the treatment of metastatic prostate carcinoma by reviewing preclinical studies and initial clinical trials performed in this field.


Assuntos
Neoplasias Ósseas/terapia , Imunoterapia , Neoplasias da Próstata/terapia , Neoplasias Ósseas/secundário , Ensaios Clínicos como Assunto , Progressão da Doença , Humanos , Metástase Linfática , Masculino , Neoplasias da Próstata/patologia
14.
J Immunother ; 22(4): 308-14, 1999 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-10404432

RESUMO

We investigated the combination therapy of local radiation of lung metastasis and vaccination with autologous tumor cells that produced interleukin (IL)-2, interferon-gamma (IFN-gamma), and granulocyte-macrophage colony-stimulating factor (GM-CSF) using the mouse Renca pulmonary metastasis model. Wild-type Renca (W/Renca) were transfected with pEF-BOS vector incorporating cDNAs for IL-2, IFN-gamma, or GM-CSF to express these cytokines. W/Renca, IL-2-producing Renca (Renca/IL-2), and IFN-gamma-producing Renca (Renca/IFN-gamma) produced subcutaneous tumor at the injection site in eight of eight, one of eight, and two of eight mice, respectively. No tumors were found in the GM-CSF-producing Renca (Renca/GM-CSF) group (zero of eight). Renca/IFN-gamma produced subcutaneous (s.c.) tumors in all Balb/c nude mice, but Renca/IL-2 and Renca/GM-CSF did not. To test the elicitation of antitumor activity, Balb/c mice were injected intravenously with 1 x 10(5) W/Renca on day 0, vaccinated, s.c., with 1 x 10(6) cells each of 5,000 rad preirradiated Renca/IL-2, Renca/IFN-gamma, and Renca/GM-CSF or 3 x 10(6) cells of preirradiated W/Renca on days 1, 7, and 14, and radiated with 300 rad to both lungs on day 5. The animals were killed on day 21 and tumor nodules in the lungs were enumerated. Neither local irradiation alone nor the combination of lung radiation and multiple vaccination with irradiated W/Renca significantly reduced the number of lung tumors. In contrast, the combination of lung radiation and the multiple vaccinations with cytokine-producing Renca cells significantly reduced the number of lung tumors. This regimen was more effective than the multiple vaccinations with cytokine-producing Renca cells alone. These studies demonstrate the efficacy of vaccination with autologous tumor cells expressing these cytokines and sensitization of the tumor target with radiation.


Assuntos
Vacinas Anticâncer/uso terapêutico , Carcinoma de Células Renais/secundário , Carcinoma de Células Renais/terapia , Citocinas/imunologia , Neoplasias Pulmonares/secundário , Neoplasias Pulmonares/terapia , Animais , Vacinas Anticâncer/farmacologia , Carcinoma de Células Renais/radioterapia , Terapia Combinada , Citocinas/metabolismo , Sinergismo Farmacológico , Feminino , Fator Estimulador de Colônias de Granulócitos e Macrófagos/imunologia , Fator Estimulador de Colônias de Granulócitos e Macrófagos/metabolismo , Imunidade Celular/efeitos dos fármacos , Imunidade Celular/imunologia , Interferon gama/imunologia , Interferon gama/metabolismo , Interleucina-2/imunologia , Interleucina-2/metabolismo , Neoplasias Renais/patologia , Neoplasias Renais/radioterapia , Neoplasias Renais/terapia , Neoplasias Pulmonares/radioterapia , Camundongos , Camundongos Endogâmicos BALB C
15.
J Neurosci Res ; 55(6): 762-9, 1999 Mar 15.
Artigo em Inglês | MEDLINE | ID: mdl-10220116

RESUMO

The present study was designed to determine whether the sensitization of locomotor activity that results from chronic phencyclidine (PCP) administration is associated with altered NMDA receptor function or mRNA in rat brain. Female Sprague-Dawley rats were administered PCP (20 mg/kg, i.p.) once daily for 5 days. After withdrawal for 72 hr, challenge with 3.2 mg/kg PCP (i.p.) revealed a significant sensitization to the locomotor activating effect of PCP. In situ hybridization analysis with an oligonucleotide probe complementary to the mRNA encoding the NR1 subunit of the NMDA receptor demonstrated that chronic PCP treatment resulted in a marked increase in NR1 subunit mRNA in the forebrain. Quantitative image analysis revealed a significant increase in the labeling of NR1 mRNA in the olfactory tubercle, piriform cortex, frontal cortex, and anterior striatum. However, no significant difference between PCP and saline-treated rats was found in the hippocampus or cerebellum. In a parallel study, possible functional alterations in the NMDA receptor were assessed by measuring NMDA-stimulated release of [3H]DA from slices of the olfactory tubercle and piriform cortex. NMDA-stimulated release was not affected by chronic PCP treatment, but the inhibition of this release by PCP, 7-chlorokynurenic acid (7-CK), and DL-2-amino-5-phosphovaleric acid (AP-5) was significantly diminished by chronic PCP. This suggests that the behavioral plasticity associated with chronic PCP may be related to an altered subunit stoichiometry of NMDA receptors in selective forebrain regions.


Assuntos
Fenciclidina/farmacologia , Prosencéfalo/metabolismo , Receptores de N-Metil-D-Aspartato/genética , Transcrição Gênica/efeitos dos fármacos , Animais , Córtex Cerebral/metabolismo , Corpo Estriado/metabolismo , Feminino , Lobo Frontal/metabolismo , Atividade Motora/efeitos dos fármacos , Bulbo Olfatório/metabolismo , Prosencéfalo/efeitos dos fármacos , RNA Mensageiro/genética , Ratos , Ratos Sprague-Dawley , Síndrome de Abstinência a Substâncias
16.
Synapse ; 31(3): 229-39, 1999 Mar 01.
Artigo em Inglês | MEDLINE | ID: mdl-10029241

RESUMO

Phencyclidine (PCP) is a drug of abuse that produces schizophrenia-like symptoms in humans and increases locomotor activity and stereotypic behavior in rodents. PCP-induced alteration in rat locomotor activity is thought to be mediated by an inhibition of N-methyl-D-aspartate (NMDA) receptors in the striatum and other brain regions. In this study, rats treated chronically with PCP (20 mg/kg once per day for 5 days) showed a marked increase in locomotor activity following a PCP challenge (3.2 mg/kg) administered after either 3 or 8 days of withdrawal. In biochemical assays, the release of striatal [14C]GABA by NMDA was enhanced by about 77% by chronic PCP treatment, whereas [3H]ACh release was increased by about 31% in tissue from PCP-treated rats. Even though binding experiments with 1-[1-(2-thiethyl)cyclohexyl]piperidyl-3,4 3H(N) ([3H]TCP) showed no alteration in the Kd or Bmax in whole striatum, quantitative immunocytochemical experiments found an upregulation in the NR1 subunit in the cell bodies and neuropil of cortical and striatal regions of the forebrain following chronic PCP treatment. An increase in the size of NR1-immunoreactive cells in the forebrain was also observed following chronic PCP treatment. Together, these data may help in understanding the mechanisms underlying the adaptive response to chronic reduction in glutamatergic NMDA transmission that has been postulated to be involved in the etiology of schizophrenia.


Assuntos
Corpo Estriado/efeitos dos fármacos , Antagonistas de Aminoácidos Excitatórios/farmacologia , Atividade Motora/efeitos dos fármacos , Fragmentos de Peptídeos/metabolismo , Fenciclidina/farmacologia , Receptores de N-Metil-D-Aspartato/antagonistas & inibidores , Animais , Imuno-Histoquímica , Masculino , Membranas/efeitos dos fármacos , Membranas/metabolismo , Ensaio Radioligante , Ratos , Ratos Sprague-Dawley , Receptores de N-Metil-D-Aspartato/química , Fatores de Tempo , Regulação para Cima
17.
Ann Biomed Eng ; 27(6): 830-8, 1999.
Artigo em Inglês | MEDLINE | ID: mdl-10625154

RESUMO

Marine biologists use a measurement called the "Dorsal Ratio" in the process of manual identification of bottlenose dolphins. The dorsal ratio denotes the relative distances of the two largest notches from the tip on the dorsal fin. The manual computation of this ratio is time consuming, labor intensive, and user dependent. This paper presents a computer-assisted system to extract the dorsal ratio for use in identification of individual animals. The first component of the system consists of active contour modeling where the trailing edge of the dorsal fin is detected. This is followed by a curvature module to find the characteristic fin points: tip and two most prominent notches. Curvature smoothing is performed at various smoothing scales, and wavelet coefficients are utilized to select an appropriate smoothing scale. The dorsal ratio is then computed from the curvature function at the appropriate smoothing scale. The system was tested using 296 digitized images of dolphins, representing 94 individual dolphins. The results obtained indicate that the computer extracted dorsal ratio can be used in place of the manually extracted dorsal ratio as part of the manual identification process.


Assuntos
Algoritmos , Pesos e Medidas Corporais/métodos , Golfinhos/anatomia & histologia , Processamento de Imagem Assistida por Computador/métodos , Fotografação , Animais , Comportamento Animal , Individualidade , Fotografação/métodos , Reprodutibilidade dos Testes , Interface Usuário-Computador
19.
Cancer Res ; 58(18): 4047-51, 1998 Sep 15.
Artigo em Inglês | MEDLINE | ID: mdl-9751607

RESUMO

Previously, we found a positive correlation between the expression of platelet-type 12-lipoxygenase (12-LOX) and the progression of human prostate adenocarcinoma (PCa; Gao et al., Urology, 46: 227-237, 1995). To determine the role of 12-LOX in PCa progression, we generated stable 12-LOX-transfected PC3 cells, which synthesize high levels of 12-LOX protein and 12(S)-hydroxyeicosatetraenoic acid metabolite. In vitro, 12-LOX-transfected PC3 cells demonstrated a proliferation rate similar to neo controls. However, following s.c. injection into athymic nude mice, 12-LOX-transfected PC3 cells formed larger tumors than did the controls. Decreased necrosis and increased vascularization were observed in the tumors from 12-LOX-transfected PC3 cells. Both endothelial cell migration and Matrigel implantation assays indicate that 12-LOX-transfected PC3 cells were more angiogenic than their neo controls. These data indicate that 12-LOX stimulates human PCa tumor growth by a novel angiogenic mechanism.


Assuntos
Araquidonato 12-Lipoxigenase/fisiologia , Proteínas de Neoplasias/fisiologia , Neovascularização Patológica/patologia , Neoplasias da Próstata/irrigação sanguínea , Ácido 12-Hidroxi-5,8,10,14-Eicosatetraenoico/fisiologia , Animais , Araquidonato 12-Lipoxigenase/genética , Divisão Celular , Humanos , Masculino , Camundongos , Camundongos Endogâmicos BALB C , Camundongos Nus , Proteínas de Neoplasias/genética , Neovascularização Patológica/enzimologia , Neoplasias da Próstata/enzimologia , Neoplasias da Próstata/patologia , Ratos , Transfecção
20.
Acta Histochem ; 100(3): 271-8, 1998 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-9717564

RESUMO

Proteoglycans (PGs) were localized in the predentine and dentine of young larvae from the urodelan species Salamandra salamandra. After cuprolinic blue (CB) staining at the critical electrolyte concentration of 0.1 M MgCl2, CB-positive, electron dense filaments with considerable variations in length and width were found in the collagen-free zone adjacent to the odontoblast processes (length up to 1.3 microns, width 21 nm), in predentine (660 nm/3.2 nm), in dentine around (20 nm/9 nm) and in the dentine tubules (35-150 nm/8 nm). Size classes very likely represent different PGs.


Assuntos
Proteoglicanas/metabolismo , Salamandridae/metabolismo , Dente/metabolismo , Animais , Dentina/metabolismo , Indicadores e Reagentes , Indóis/metabolismo , Larva/metabolismo , Compostos Organometálicos/metabolismo , Coloração e Rotulagem/métodos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA